Responses
Oral Plenary
Plenary I
IGCS20_1256
1 Avelumab in combination with and/or following chemotherapy vs chemotherapy in treatment-naive patients with ovarian cancer: biomarker analyses from the phase 3 JAVELIN Ovarian 100 trial
Compose a Response to This Article
Other responses
No responses have been published for this article.